133 related articles for article (PubMed ID: 35654390)
1. Epigenetic modification facilitates proline synthase PYCR1 aberrant expression in gastric cancer.
Xiao S; Yao X; Ye J; Tian X; Yin Z; Zhou L
Biochim Biophys Acta Gene Regul Mech; 2022 Aug; 1865(6):194829. PubMed ID: 35654390
[TBL] [Abstract][Full Text] [Related]
2. Pyrroline-5-carboxylate reductase 1 (PYCR1) upregulation contributes to gastric cancer progression and indicates poor survival outcome.
Xiao S; Li S; Yuan Z; Zhou L
Ann Transl Med; 2020 Aug; 8(15):937. PubMed ID: 32953737
[TBL] [Abstract][Full Text] [Related]
3. SIRT3 regulates cancer cell proliferation through deacetylation of PYCR1 in proline metabolism.
Chen S; Yang X; Yu M; Wang Z; Liu B; Liu M; Liu L; Ren M; Qi H; Zou J; Vucenik I; Zhu WG; Luo J
Neoplasia; 2019 Jul; 21(7):665-675. PubMed ID: 31108370
[TBL] [Abstract][Full Text] [Related]
4. PYCR in Kidney Renal Papillary Cell Carcinoma: Expression, Prognosis, Gene Regulation Network, and Regulation Targets.
Shao Z; Lu L; Cui Y; Deng L; Xu Q; Liang Q; Lu X; Zhang J; Chen J; Situ Y
Front Biosci (Landmark Ed); 2022 Dec; 27(12):336. PubMed ID: 36624948
[TBL] [Abstract][Full Text] [Related]
5. Metabolic pathway analyses identify proline biosynthesis pathway as a promoter of liver tumorigenesis.
Ding Z; Ericksen RE; Escande-Beillard N; Lee QY; Loh A; Denil S; Steckel M; Haegebarth A; Wai Ho TS; Chow P; Toh HC; Reversade B; Gruenewald S; Han W
J Hepatol; 2020 Apr; 72(4):725-735. PubMed ID: 31726117
[TBL] [Abstract][Full Text] [Related]
6. Human mitochondrial pyrroline-5-carboxylate reductase 1 promotes invasiveness and impacts survival in breast cancers.
Ding J; Kuo ML; Su L; Xue L; Luh F; Zhang H; Wang J; Lin TG; Zhang K; Chu P; Zheng S; Liu X; Yen Y
Carcinogenesis; 2017 May; 38(5):519-531. PubMed ID: 28379297
[TBL] [Abstract][Full Text] [Related]
7. Genetic analysis of Pycr1 and Pycr2 in mice.
Stum MG; Tadenev ALD; Seburn KL; Miers KE; Poon PP; McMaster CR; Robinson C; Kane C; Silva KA; Cliften PF; Sundberg JP; Reinholdt LG; John SWM; Burgess RW
Genetics; 2021 May; 218(1):. PubMed ID: 33734376
[TBL] [Abstract][Full Text] [Related]
8. PYCR1, BANF1, and STARD8 Expression in Gastric Carcinoma: A Clinicopathologic, Prognostic, and Immunohistochemical Study.
Harb OA; Elfeky MA; Alabiad MA; Hemeda R; Allam AS; El Hawary AT; Elbaz M; Sharaf AL; Gertallah LM; Abdelaziz AM; Shalaby AM; Alorini M; Yahia AIO; Negm M
Appl Immunohistochem Mol Morphol; 2024 Feb; 32(2):102-110. PubMed ID: 37982568
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA hsa-miR-150-5p inhibits nasopharyngeal carcinogenesis by suppressing PYCR1 (pyrroline-5-carboxylate reductase 1).
Li Z; Zhou X; Huang J; Xu Z; Xing C; Yang J; Zhou X
Bioengineered; 2021 Dec; 12(2):9766-9778. PubMed ID: 34696668
[TBL] [Abstract][Full Text] [Related]
10. MYC regulation of glutamine-proline regulatory axis is key in luminal B breast cancer.
Craze ML; Cheung H; Jewa N; Coimbra NDM; Soria D; El-Ansari R; Aleskandarany MA; Wai Cheng K; Diez-Rodriguez M; Nolan CC; Ellis IO; Rakha EA; Green AR
Br J Cancer; 2018 Jan; 118(2):258-265. PubMed ID: 29169183
[TBL] [Abstract][Full Text] [Related]
11.
Christensen EM; Bogner AN; Vandekeere A; Tam GS; Patel SM; Becker DF; Fendt SM; Tanner JJ
J Biol Chem; 2020 Dec; 295(52):18316-18327. PubMed ID: 33109600
[TBL] [Abstract][Full Text] [Related]
12. Deciphering the effects of PYCR1 on cell function and its associated mechanism in hepatocellular carcinoma.
Xu Y; Zuo W; Wang X; Zhang Q; Gan X; Tan N; Jia W; Liu J; Li Z; Zhou B; Zhao D; Xie Z; Tan Y; Zheng S; Liu C; Li H; Chen Z; Yang X; Huang Z
Int J Biol Sci; 2021; 17(9):2223-2239. PubMed ID: 34239351
[TBL] [Abstract][Full Text] [Related]
13. Structure, biochemistry, and gene expression patterns of the proline biosynthetic enzyme pyrroline-5-carboxylate reductase (PYCR), an emerging cancer therapy target.
Bogner AN; Stiers KM; Tanner JJ
Amino Acids; 2021 Dec; 53(12):1817-1834. PubMed ID: 34003320
[TBL] [Abstract][Full Text] [Related]
14. Pyrroline-5-Carboxylate Reductase 1: a novel target for sensitizing multiple myeloma cells to bortezomib by inhibition of PRAS40-mediated protein synthesis.
Oudaert I; Satilmis H; Vlummens P; De Brouwer W; Maes A; Hose D; De Bruyne E; Ghesquière B; Vanderkerken K; De Veirman K; Menu E
J Exp Clin Cancer Res; 2022 Feb; 41(1):45. PubMed ID: 35105345
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic silencing of miR-137 is a frequent event in gastric carcinogenesis.
Steponaitiene R; Kupcinskas J; Langner C; Balaguer F; Venclauskas L; Pauzas H; Tamelis A; Skieceviciene J; Kupcinskas L; Malfertheiner P; Link A
Mol Carcinog; 2016 Apr; 55(4):376-86. PubMed ID: 25663388
[TBL] [Abstract][Full Text] [Related]
16. Pro-tumorigenic activity of PYCR1 in gastric cancer through regulating the PI3K/AKT signaling.
Xiao H; Huang J; Wu H; Li Y; Wang Y
Heliyon; 2024 Mar; 10(5):e26883. PubMed ID: 38455525
[TBL] [Abstract][Full Text] [Related]
17. Pyrroline-5-Carboxylate Reductase 1 Accelerates the Migration and Invasion of Nonsmall Cell Lung Cancer
Sang S; Zhang C; Shan J
Cancer Biother Radiopharm; 2019 Aug; 34(6):380-387. PubMed ID: 30916574
[No Abstract] [Full Text] [Related]
18. ONECUT2 upregulation is associated with CpG hypomethylation at promoter-proximal DNA in gastric cancer and triggers ACSL5.
Seo EH; Kim HJ; Kim JH; Lim B; Park JL; Kim SY; Lee SI; Jeong HY; Song KS; Kim YS
Int J Cancer; 2020 Jun; 146(12):3354-3368. PubMed ID: 32129880
[TBL] [Abstract][Full Text] [Related]
19. Metabolomic and transcriptomic studies of improvements in myocardial infarction due to Pycr1 deletion.
Xue Z; Pan Y; Kong X; Zhang J; Wu D; Zhou B
J Cell Mol Med; 2023 Jan; 27(1):89-100. PubMed ID: 36495058
[TBL] [Abstract][Full Text] [Related]
20. Cancer-associated fibroblasts require proline synthesis by PYCR1 for the deposition of pro-tumorigenic extracellular matrix.
Kay EJ; Paterson K; Riera-Domingo C; Sumpton D; Däbritz JHM; Tardito S; Boldrini C; Hernandez-Fernaud JR; Athineos D; Dhayade S; Stepanova E; Gjerga E; Neilson LJ; Lilla S; Hedley A; Koulouras G; McGregor G; Jamieson C; Johnson RM; Park M; Kirschner K; Miller C; Kamphorst JJ; Loayza-Puch F; Saez-Rodriguez J; Mazzone M; Blyth K; Zagnoni M; Zanivan S
Nat Metab; 2022 Jun; 4(6):693-710. PubMed ID: 35760868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
